Head-to-head · Value Score
CoreAge Rx vs NEUVÉ Health
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 81, NEUVÉ Health a 75. Here's what each one really costs past month one — and where each one bites back.
CoreAge Rx
Grade B · Good Value
Advertised price
From $79/mo
From $79/mo (compounded semaglutide; confirm total at checkout)
NEUVÉ Health
Grade C+ · Fair Price
Advertised price
$170/mo
$170/mo (injectable standard dose compounded with glycine; $217/mo with B12)
Save ~51% vs brand self-payThe verdict
CoreAge Rx takes it on Value Score, 81 to 75 — an est. From $79/mo (compounded semaglutide; confirm total at checkout) first month, though we flag its pricing to watch. NEUVÉ Health isn't out of it: Shoppers who want to compare an injectable against a daily sublingual at the same desk, and who will get the question of what is included answered in writing first.
CoreAge Rx is a featured partner of this site. Its advertised prices have checkout conditions, and state eligibility is confirmed during intake.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | NEUVÉ Health |
|---|---|---|
| Value Score | 81 (B) | 75 (C+) |
| Advertised price | From $79/mo (compounded semaglutide; confirm total at checkout) | $170/mo (injectable standard dose compounded with glycine; $217/mo with B12) |
| Save vs brand self-pay | — | ~51% |
| Semaglutide | From $79/mo (compounded injection; confirm total at checkout) | $170/mo (injectable standard dose compounded with glycine; $217/mo with B12) |
| Tirzepatide | From $129/mo (compounded injection; confirm total at checkout) | $324/mo (injectable standard dose; $282/mo as a daily sublingual) |
| Both molecules | Yes | Yes |
| Pricing | Watch | Watch |
| Coverage | U.S., state limits shown at intake | All 50 states claimed, with members in 40+ |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
CoreAge Rx advertises compounded semaglutide from $79 and tirzepatide from $129 per month, with dose-flat pricing stated in its FAQ. Confirm the total and refund terms before paying.
What's good
- CoreAge Rx publishes separate product prices for both molecules: semaglutide from $79 per month and tirzepatide from $129. That gives you two actual medication offers to compare rather than one generic GLP-1 starting figure.
- CoreAge Rx's FAQ says the price locked in at checkout stays the same in future months regardless of dose increases. I would save that confirmation with the order, because a low starting price matters much more when the prescribed maintenance dose costs the same.
- The product pages state that there are no long-term contracts or membership fees and advertise fast, free delivery. Compare those inclusions with the checkout total; the refund policy separately allows applicable consultation fees and shipping charges if disclosed there.
- CoreAge Rx uses the MD Integrations professional entities for medical care and prescribing. Its FAQ names physicians assigned in California, Massachusetts, Rhode Island and Vermont, giving patients in those states a concrete medical contact to verify.
- CoreAge Rx offers account-based reordering and cancellation, and its help center says optional subscriptions can be managed in the member portal. Check whether your selected purchase is a one-time order or an automatically renewed subscription so the next charge is predictable.
- CoreAge Rx also advertises microdosing products at $79 for semaglutide and $129 for tirzepatide. These are separate lower-dose offers, not a reason to select your own dose or evidence that they work like the doses studied for approved products.
The fine print
- CoreAge Rx's FAQ promises an automatic 100% refund if the clinician declines your prescription, but its refund policy says applicable consultation fees of $50–$100 are nonrefundable. Ask which policy applies to the exact order and how much would be returned before you pay.
- CoreAge Rx's refund policy makes a medication order final once the prescription is approved and sent to the pharmacy, which can happen before shipping. Waiting until the parcel is dispatched may be too late to cancel an order or recover the medication charge. The policy also imposes a 30-day nonrefundable cutoff even when incomplete documentation has prevented fulfillment.
- CoreAge Rx does not publish a complete GLP-1 state list. Its FAQ says therapy-specific state restrictions are confirmed during intake, so a U.S. address alone does not establish that your selected medication is available where you live.
- CoreAge Rx does not name the dispensing pharmacy in its FAQ; it asks patients to contact support. Obtain the pharmacy's legal name, license and contact information before choosing a compounded prescription. The platform's branding does not identify who prepares your medication.
- CoreAge Rx's FAQ says there are no automatic rebills, while its refund policy and help center describe optional automatic renewals. I would confirm the selected purchase option and next charge date rather than treat the general FAQ answer as a guarantee for every order.
- CoreAge Rx offers compounded medication, which is not FDA-approved. Its FAQ says tirzepatide is typically formulated with B12 and that requests without it go to the prescriber. Ask why the exact formulation is appropriate for you; an added vitamin does not itself establish a lawful patient-specific difference.
NEUVÉ Health
Twelve GLP-1 prices published one per product with no plan ladder and no introductory month — sold under a heading promising all-in monthly pricing that the same page's fine print contradicts.
What's good
- Twelve GLP-1 prices are published before any intake, one per product rather than as a range: $170 and $217 for standard semaglutide depending on the compounding, $324 for standard tirzepatide, and $138 to $160 for the daily sublingual low-dose products
- There is no introductory month, no prepay ladder and no commitment tier on the site at all, so the advertised figure is the recurring figure — the trap this site exists to catch is absent
- The compounding is disclosed per product: whether the injection is prepared with B12 or with glycine is on the card, which lets a buyer with a B12 preference choose on a fact rather than an assumption
- Both routes are covered at full dose and low dose, so the daily sublingual and the weekly injection can be compared at the same desk on published numbers
- The pharmacy class is now stated — compounded by a 503A pharmacy, with fulfillment through 503A or 503B facilities — which is more than most GLP-1 sellers put in writing
- Cancellation is stated once and plainly: cancel at any time, future charges stop, past periods are not refunded
The fine print
- The site gives three different answers to whether the medication is inside the price. The weight-loss page is headed "all-in monthly pricing" and its own fine print says medication, labs and treatment supplies are billed separately — and the clinical partner that would settle it is not named
- Three membership tiers are named once, in the financial policy, and priced nowhere on the site
- Four different starting floors are advertised across the site, and the lowest belongs to a different treatment line entirely, so the cheapest number a shopper meets is not a weight-loss price
- Every legal page — terms, privacy, refund and financial — ends by saying it is plain-English summary copy being reviewed by counsel and subject to change before public launch, on a site that is live and taking payment
- The homepage claims all fifty states and, on the same page, members in more than forty, without the distinction the about page draws; the financial policy narrows it further to an Arizona-licensed clinician
- No compounding pharmacy is named, no medical group is named and no clinician identifier is published — the only named people are a founder and one practitioner seen once in the signup
- No phone number is published anywhere on the site, and the support address sits on a different domain from the one selling the treatment
- One low-dose product card's inclusion list names the wrong molecule, which on a prescription product is not a typographical matter
We earn a commission when you start treatment through some links on this site, at no extra cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to NEUVÉ Health.
More head-to-heads
The programs scoring closest to this pair, side by side.
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. "% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on each provider's site. Not medical advice; see our disclosure.